Arkolith/Insider Trading/CAI/Form 4

Denton John Russel

See RemarksCaris Life Sciences, Inc. (CAI) · full profile →Form 4 · filed Jun 23, 2025
Net Buying
Open-Market Buys
$158K
Open-Market Sells
$0
Net Open-Market Flow
$158K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Buy(P)8K$21.00$158K124K
Jun 18, 2025Grant(A)99K—$0116K
Mar 3, 2025Disposed to issuer(D)238K$18.60$4.4M17K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2025Grant(A)255K—$0255K

Transaction Codes

P
Open-market purchase
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-061810) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML